Drug Manufacturing
-
Vetter prepares for further growth
As part of its business growth strategy, Vetter has announced that a triple-digit million euro syndicated loan has been arranged with a consortium of banks led by Deutsche Bank AG, the Landesbank Baden-Württemberg, and Commerzbank AG.
Drug Manufacturing | 25 May 2012
-
Global generic drug markets will grow to US$221 billion by 2016
Driven by the need to control costs, the use of generic drugs has grown considerably in recent years, even in markets where traditionally they have not been favored.
Drug Manufacturing | 23 May 2012
-
Astellas site implements Werum’s PAS-X
The MES will introduce efficient and state-of-the-art paperless electronic batch recording functionality supporting compliant, efficient and lean production processes.
Drug Manufacturing | 22 May 2012
-
US Supreme Court clears way for generic patent challenges
After the ruling, generic manufacturers will now be able to challenge the content of patent descriptions and, if successful, ultimately force approval of the ANDA. Writing for the Court in a unanimous decision, Justice Elena Kagan chastised the FDA for using ambiguous or opaque guidelines and forms that lend to the confusion surrounding patent decisions.
Drug Manufacturing | 18 May 2012
-
Pharmaceutical giants set to lose dominance in urological disorders market
Major pharmaceutical companies are predicted to lose their footing in the urological disorders market by 2017, a report by GBI Research has found.
Drug Manufacturing | 17 May 2012
-
Watson in talks to buy Actavis
Watson Pharmaceuticals is currently in talks to buy private Swiss generic drug maker Actavis.
Drug Manufacturing | 11 May 2012
-
Kuehne + Nagel launches innovative airfreight solution for pharmaceutical products
KN PharmaChain offers – among other features – door-to-door temperature control, a 24 hour alert system, optional wireless temperature measuring and best practice (GxP) standards for facilities, working processes and training programmes.
Drug Manufacturing | 08 May 2012
-
More investment needed in anti-obesity drugs
Pharmaceutical companies should increase their investment in anti-obesity drug therapies to support the growing number of clinically obese individuals worldwide, a report by GlobalData has found.
Drug Manufacturing | 01 May 2012
-
China remains one of the fastest growing pharmaceutical markets in the world
China and Japan will be the largest and second largest pharmaceutical markets in the Asia Pacific region in 2016.
Drug Manufacturing | 27 April 2012
-
Merck donates five mobile compact labs for detecting counterfeit medicines to Zambia
To help improve health care in Zambia, the Global Pharma Health Fund, a charitable initiative funded by Merck, has donated five mobile compact laboratories to the Health Ministry in the capital city of Lusaka to help detect counterfeit medicines.
Drug Manufacturing | 24 April 2012
